Our findings indicate that AMPK may be an essential regulator of the c-Myc-mediated transcriptional program in transformed colonic cancer whilst adapting to metabolic fluctuations during carcinogenesis, which would explain why the preventive effect of salicylate on CRC is protracted and requires chronic treatment with high levels. The gene discussed is MYC; the disease is colonic neoplasm.